CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 198 filers reported holding CHEMOCENTRYX INC in Q2 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $354,000 | -51.2% | 14,287 | -50.6% | 0.00% | -33.3% |
Q1 2022 | $725,000 | -78.4% | 28,903 | -68.7% | 0.00% | -66.7% |
Q4 2021 | $3,362,000 | +212.5% | 92,339 | +46.7% | 0.01% | +200.0% |
Q3 2021 | $1,076,000 | -63.4% | 62,938 | -71.3% | 0.00% | -72.7% |
Q2 2021 | $2,938,000 | -14.2% | 219,403 | +251.3% | 0.01% | -76.1% |
Q3 2020 | $3,423,000 | +1470.2% | 62,458 | +1051.7% | 0.05% | +666.7% |
Q1 2020 | $218,000 | -90.4% | 5,423 | -90.6% | 0.01% | -57.1% |
Q4 2019 | $2,270,000 | +168.6% | 57,393 | -54.0% | 0.01% | +75.0% |
Q3 2019 | $845,000 | -58.5% | 124,685 | -43.0% | 0.01% | -60.0% |
Q2 2019 | $2,034,000 | +117.8% | 218,700 | +225.4% | 0.02% | +100.0% |
Q1 2019 | $934,000 | +19.9% | 67,218 | -5.9% | 0.01% | +11.1% |
Q4 2018 | $779,000 | -29.9% | 71,403 | -18.8% | 0.01% | -30.8% |
Q3 2018 | $1,112,000 | +0.4% | 87,975 | +4.5% | 0.01% | -13.3% |
Q2 2018 | $1,108,000 | +726.9% | 84,154 | +272.8% | 0.02% | +650.0% |
Q4 2017 | $134,000 | +36.7% | 22,574 | +71.6% | 0.00% | 0.0% |
Q3 2017 | $98,000 | – | 13,156 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,796,516 | $45,142,000 | 7.90% |
GREAT POINT PARTNERS LLC | 1,000,000 | $5,790,000 | 4.09% |
Belmont Global Advisors, Inc. | 175,000 | $1,013,000 | 0.82% |
Broadfin Capital, LLC | 1,033,668 | $5,985,000 | 0.79% |
WASATCH ADVISORS LP | 2,650,551 | $15,347,000 | 0.15% |
BALYASNY ASSET MANAGEMENT L.P. | 1,158,613 | $6,708,000 | 0.09% |
Artal Group S.A. | 275,000 | $1,592,000 | 0.06% |
STONERIDGE INVESTMENT PARTNERS LLC | 41,355 | $239,000 | 0.05% |
A.R.T. Advisors, LLC | 33,501 | $193,000 | 0.01% |
BANQUE PICTET & CIE SA | 50,932 | $295,000 | 0.01% |